[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100435984":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":32,"centralContacts":37,"locations":46,"responsibleParty":87,"collaborators":90,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":42,"eligibilityCriteria":100,"healthyVolunteers":96,"sex":101,"minAge":102,"maxAge":42,"enrollmentInfo":103,"targetDuration":42,"studyType":106,"phases":107,"briefSummary":109,"conditions":110,"keywords":42,"overallStatus":73,"whyStopped":42,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"Rigshospitalet, Denmark","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"BAK-preserved","ACTIVE_COMPARATOR","Xalatan eye drop",[13],"Drug: Xalatan",{"label":15,"type":10,"description":16,"interventionNames":17},"Preservative-free","Monoprost eye drop",[18],"Drug: Monoprost",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Xalatan","Eye drop",[9],[26],"BAK-preserved latanoprost",{"type":21,"name":28,"description":23,"armGroupLabels":29,"otherNames":30},"Monoprost",[15],[31],"Preservative-free latanoprost",[33],{"name":34,"affiliation":35,"role":36},"Miriam Kolko, MD, PhD","Department of ophthalmology, rigshospitalet-Glostrup","PRINCIPAL_INVESTIGATOR",[38,44],{"name":39,"role":40,"phone":41,"phoneExt":42,"email":43},"Anne Nagstrup, MD","CONTACT","+4522334504",null,"anne.hedengran.nagstrup@regionh.dk",{"name":34,"role":40,"phone":42,"phoneExt":42,"email":45},"miriamk@sund.ku.dk",[47,71],{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Department of ophthalmology, rigshospitalet.glostrup","NOT_YET_RECRUITING","Glostrup Municipality","Danmark","2600","Denmark","DK",{"type":56,"coordinates":57},"Point",[58,59],12.40377,55.6666,{"lat":59,"lon":58},[62,64,66,68],{"name":39,"role":40,"phone":63,"phoneExt":42,"email":43},"22334504",{"name":65,"role":40,"phone":42,"phoneExt":42,"email":45},"Miriam Kolko, MD, Phd",{"name":67,"role":36,"phone":42,"phoneExt":42,"email":42},"Miriam Kolko",{"name":69,"role":70,"phone":42,"phoneExt":42,"email":42},"Anne Nagstrup","SUB_INVESTIGATOR",{"facility":72,"status":73,"city":74,"state":42,"zip":75,"country":53,"countryCode":54,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Department of drug design and pharmacology, University of Copenhagen","RECRUITING","Copenhagen","2100",{"type":56,"coordinates":77},[78,79],12.56553,55.67594,{"lat":79,"lon":78},[82,83,84,85],{"name":39,"role":40,"phone":42,"phoneExt":42,"email":42},{"name":34,"role":40,"phone":42,"phoneExt":42,"email":42},{"name":34,"role":36,"phone":42,"phoneExt":42,"email":42},{"name":86,"role":70,"phone":42,"phoneExt":42,"email":42},"Anne Nafstrup, MD",{"type":36,"investigatorFullName":88,"investigatorTitle":89,"investigatorAffiliation":5,"oldNameTitle":42,"oldOrganization":42},"Anne Hedengran Nagstrup","Department of ophthalmology",[91],{"name":92,"class":93},"Laboratoires Thea","INDUSTRY","100435984","phase-4-effect-of-benzalkonium-chloride-preserved-and-preservative-free-latanoprost-eye-drops-on-conjunctival-goblet-cells-100435984",false,"NCT04957329","Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells","Department of Ophthalmology, Rigshospitalet-Glostrup Valdemar Hansens Vej 13, 2600 Glostrup, Denmark","Inclusion Criteria:\n\n1. Age \\>18years\n2. Danish speaking\n3. Open angle glaucoma or ocular hypertension\n4. Average intraocular pressure equal to or above 22 mmHg\n\nExclusion Criteria:\n\na. history of significant eye diseae (including okular trauma) other than open angle glaucoma and ocular hypertension d. treatment with steroids within the last 3 months from inclusion e. Significant untreated systemic disease such as hypertension, heart failure, diabetes mellitus, stroke, lung disease and autoimmune diseases. Diseases are not reason for exclusion if they are well treated or does not need treatment g. pregnant or breast feeding h. women using unsafe anticonception i. allergy towards trial medication j. patients who cannot cooperate in eye examination k. ocular surface defects l. need for polytherapy in glaucoma treatment","ALL","18 Years",{"count":104,"type":105},28,"ESTIMATED","INTERVENTIONAL",[108],"PHASE4","a randomized, investigator-blind, interventinal study will compare the effect of benzalkonium-chloride (BAK) preserved and preservative-free (PF) eye drops on conjunctival goblet cells.",[111,112],"Glaucoma","Ocular Hypertension","2023-11-15",{"date":115,"type":116},"2023-11-18","ACTUAL",{"date":118,"type":116},"2021-09-01",{"date":120,"type":105},"2026-12-31",{"name":5,"class":6},2]